Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation

Blood

Volumn 87, Issue 5, 1996, Pages 2020-2028

  Huh, Ho Young ^b   Pearce, S Frieda ^b   Yesner, Lewis M ^b   Schindler, Joseph L ^b   Silverstein, Roy L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; COLLAGEN; THROMBOSPONDIN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0000685254     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.2020.bloodjournal8752020     Document Type: Article

References (40)

1. Lewis MR: The formation of macrophages, epitheloid cells and giant cells from leukocytes in incubated blood. Am J Pathol 1:91, 1925
2. Carrel A, Ebeling AH: The fundamental properties of fibroblasts and the macrophage J Exp Med 44:285, 1926
3. van Furth R, Raebum JA, van Zwet TL: Characteristics of human mononuclear phagocytes. Blood 54:485, 1979
4. Musson RA: Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol 111:331, 1983
5. Kaplan G, Gaudernack G: In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med 156:1101, 1982
6. Murtaugh MP, Arend WP, Davies PJA: Induction of tissue transglutaminase in human peripheral blood monocytes. J Exp Med 159:114, 1984
7. Fesus L, Sandor M, Horvath LI, Bagyinka C, Erdei A, Gergely J: Immune-complex-induced transglutamonase activation: Its role in the Fc-receptor-mediated transmembrane effect on peritoneal macrophages. Mol Immunol 18.633, 1981
8. Newman SL, Musson RA, Henson PA: Development of functional complement receptors during in vitro maturation of human monocytes into macrophages J Immunol 125:2236, 1980
9. Hirata T, Bitterman PB, Mornex JF, Crystal RG: Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation. J Immunol 136:1339, 1986
10. Geng YJ, Kodama T, Hansson GK: Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 14:798, 1994
11. Kataoka M, Tavassoli M: Development of specific surface receptors recognizing mannose-terminal glycoconjugates in cultures monocytes: A possible early marker for differentiation of monocyte into macrophage. Exp Hematol 13:44, 1985
12. Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79:1054, 1987
13. Silverstein RL, Baird M, Lo SK, Yesner LM: Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. J Biol Chem 267:16607, 1992
14. Tandon NN, Kralisz U, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264:7576, 1989
15. Barnwell JM, Ockenhouse CF, Knowles DM: Monoclonal antibody OKM5 inhibits in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells J Immunol 135:3494, 1985
16. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the vitonectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90:1513, 1992
17. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 181.1857, 1995
18. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11811, 1993
19. Nicholson A, Pearce SFA, Silverstein RL: Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 15:269, 1995
20. Huh HY, Lo SK, Yesner LM, Silverstein RL: CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells. J Biol Chem 270:6267, 1995
21. Yesner LM, Huh HY, Pearce SFA, Silverstein RL: Regulation of monocyte CD36 and TSP expression by soluble mediators. Mol Bioi Cell 4:1035, 1993
22. Asch AS, Liu I, Bricetti FM, Barnwell J, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M: Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain. Science 262:1436, 1993
23. Suchard SJ, Mansfield PJ, Dixit VM: Modulation of thrombospondin receptor expression during HL-60 cell differentiation. J Immunol 152:877, 1994
24. Ockenhouse CF, Chulay JD: Plasmodium falciparum sequestration: OKM5 Antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line. J Infect Dis 157.584, 1988
25. Jaffe EA, Ruggiero JT, Falcone DJ: Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65:79, 1985
26. Schwartz BS: Monocyte synthesis of thrombospondin. J Biol Chem 264:7512, 1989
27. Silverstein RL, LaSala J, Pearce SF: CD36 cluster workshop report, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Silverstein RL, Springer TA, Tedder TF, Todd RF (eds): Leukocyte Typing V: White Cell Differentiation Antigens. Oxford, UK, Oxford University Press, 1995, p 1271
28. Pearce SFA, Wu J, Silverstein RL: A carboxy terminal truncation mutant of CD36 is secreted and binds thrombospondin: Evidence for a single transmembrane domain. Blood 84:384, 1994
29. Oquendo P, Hundt E, Lawler J, Seed B: CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58:95, 1989
30. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103:1635, 1986
31. Hammer A, Kager G, Dohr G, Rabl H, Ghassempur I, Jurgens G: Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler Throm Vasc Biol 15:704, 1995
32. Eklund A, Blaschke E: Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 41:629, 1986
33. Haines DS, Gillespie D: RNA abundance measured by a lysate RNase protection assay Biotechniques 12.736, 1992
34. Pearce SFA, Wu J, SIlverstein RL:Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. J Biol Chem 270:2981, 1995
35. Collarini EJ, Kuhn R, Marshall CJ, Monuki ES, Lemke G, Richardson WD: Down-regulation of the POU transcriptional factor SCIP is an early event in oligodendricyte differentiation in vitro. Development 116:193, 1992
36. Konig H, Pfisterer P, Corcoran LM, Wirth T: Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev 9:1598, 1995
37. Armesilla AL, Vega MA: Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 269:18985, 1994
38. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 232:34, 1986
39. Rosenfeld ME, Yla-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D: Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 140:291, 1992
40. Shimano H, Yamada N, Ishibashi S, Harada K, Matsumoto A, Mori N, Inaba T, Motoyoshi K, Itakura H, Takaku F: Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits. J Biol Chem 265:12869, 1990